Endonovo Therapeutics (ENDV) Short Interest Ratio & Short Volume → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free ENDV Stock Alerts $0.0023 0.00 (0.00%) (As of 03/27/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Endonovo Therapeutics Short Interest DataCurrent Short Volume10,000 sharesPrevious Short Volume0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$35.00Short Interest Ratio / Days to Cover0.1Last Record DateMarch 15, 2024Outstanding Shares333,040,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume10,001,873 sharesAverage Trading Volume579,632 sharesToday's Volume Vs. Average1,726% Short Selling Endonovo Therapeutics ? Sign up to receive the latest short interest report for Endonovo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatENDV Short Interest Over TimeENDV Days to Cover Over TimeENDV Percentage of Float Shorted Over Time Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> Endonovo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202410,000 shares $35.00 No ChangeN/A0.1 $0.00 2/15/202427,000 shares $118.80 +130.8%N/A0 $0.00 1/15/202421,300 shares $208.74 +309.6%N/A0 $0.01 12/31/20235,200 shares $45.24 -73.2%N/A0 $0.01 12/15/202319,400 shares $176.54 +9,600.0%N/A0 $0.01 11/30/2023200 shares $2.30 No ChangeN/A0 $0.01 Get the Latest News and Ratings for ENDV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Endonovo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/20233,700 shares $51.43 No ChangeN/A0 $0.01 9/15/20231,500 shares $16.67 No ChangeN/A0 $0.01 8/31/20231,500 shares $19.05 -60.5%N/A0 $0.01 8/15/20233,800 shares $41.80 -39.7%N/A0 $0.01 7/31/20236,300 shares $69.30 No ChangeN/A0.1 $0.01 6/30/2023300 shares $4.35 No ChangeN/A0 $0.01 4/30/202341,700 shares $417.00 -3.0%N/A0.1 $0.01 4/15/202343,000 shares $712.51 +15.0%N/A0.1 $0.02 3/31/202337,400 shares $617.10 No ChangeN/A0.1 $0.02 2/15/202322,300 shares $367.95 +2,377.8%N/A0 $0.02 1/31/2023900 shares $16.92 +50.0%N/A0 $0.02 1/15/2023600 shares $9.30 No ChangeN/A0 $0.02 12/15/2022300 shares $3.93 -78.6%N/A0 $0.01 11/30/20221,400 shares $9.94 -6.7%N/A0 $0.01 11/15/20221,500 shares $13.20 No ChangeN/A0 $0.01 10/31/20221,500 shares $12.00 -76.9%N/A0 $0.01 10/15/20226,500 shares $52.00 -13.3%N/A0 $0.01 9/30/20227,500 shares $55.50 No ChangeN/A0 $0.01 8/31/202229,000 shares $216.05 +28,900.0%N/A0.1 $0.01 8/15/2022100 shares $0.83 No ChangeN/A0 $0.01 7/15/20229,000 shares $90.00 -4.3%N/A0.1 $0.01 6/30/20229,400 shares $84.60 No ChangeN/A0 $0.01 2/28/202210,900 shares $196.20 +118.0%N/A0 $0.02 2/15/20225,000 shares $85.00 No ChangeN/A0 $0.02 9/15/2021800 shares $19.20 No ChangeN/A0 $0.02 8/13/2021600 shares $16.32 -98.7%N/A0 $0.03 7/30/202147,000 shares $1,179.70 +526.7%N/A0.1 $0.03 7/15/20217,500 shares $269.25 No ChangeN/A0 $0.04 6/15/20212,900 shares $87.29 +93.3%N/A0 $0.03 5/28/20211,500 shares $50.10 -79.7%N/A0 $0.03 5/14/20217,400 shares $295.26 No ChangeN/A0 $0.04 4/15/202136,200 shares $1,086.00 No ChangeN/A0 $0.03 3/15/202115,300 shares $676.26 No ChangeN/A0 $0.04 2/26/202115,300 shares $612.00 -55.7%N/A0 $0.04[BUY ALERT] Our #1 A.I. Stock for March (Ad)It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> ENDV Short Interest - Frequently Asked Questions What is Endonovo Therapeutics' current short interest? Short interest is the volume of Endonovo Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 10,000 shares of ENDV short. Learn More on Endonovo Therapeutics' current short interest. Is Endonovo Therapeutics' short interest increasing or decreasing? Endonovo Therapeutics saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 10,000 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Endonovo Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Endonovo Therapeutics: Escalon Medical Corp. (0.00%), Tivic Health Systems, Inc. (1.86%), Nuwellis, Inc. (12.74%), Helius Medical Technologies, Inc. (13.22%), Micron Solutions, Inc. (0.07%), SeqLL Inc. (10.87%), 180 Life Sciences Corp. (12.18%), Vyant Bio, Inc. (0.67%), Tenax Therapeutics, Inc. (2.17%), Baudax Bio, Inc. (1.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Endonovo Therapeutics stock? Short selling ENDV is an investing strategy that aims to generate trading profit from Endonovo Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Endonovo Therapeutics? A short squeeze for Endonovo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENDV, which in turn drives the price of the stock up even further. How often is Endonovo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENDV, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ESMC Short Interest TIVC Short Interest NUWE Short Interest HSDT Short Interest MICR Short Interest SQL Short Interest ATNF Short Interest VYNT Short Interest TENX Short Interest BXRX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ENDV) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings